Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79152924 | 7915292 | 4 | F | 20110405 | 20121219 | 20110426 | 20121231 | EXP | MY-BRISTOL-MYERS SQUIBB COMPANY-15690175 | BRISTOL MYERS SQUIBB | 29.00 | YR | M | Y | 0.00000 | 20121231 | CN | JP | MY |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79152924 | 7915292 | 1 | PS | ABILIFY TABS | 1 | ORAL | 6MG 8-22MAR11(15D) 12MG 23MAR-7APR11(16D) 18MG 8-12APR11(5D) | D | 0 | 18 | MG | Tablet | |||||||
| 79152924 | 7915292 | 2 | C | RISPERIDONE | 1 | D | 0 | ||||||||||||
| 79152924 | 7915292 | 3 | C | BENZHEXOL | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 79152924 | 7915292 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 79152924 | 7915292 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 79152924 | 7915292 | Insomnia | |
| 79152924 | 7915292 | Restlessness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 79152924 | 7915292 | 1 | 20110308 | 20110412 | 0 | |
| 79152924 | 7915292 | 2 | 20110308 | 20110322 | 0 | |
| 79152924 | 7915292 | 3 | 20110308 | 20110322 | 0 |